The Latest Breaking News from Vaccine

Health authorities say the vaccine is safe and effective in this age group

Across the UK Covid infections have fallen to their lowest level in two months

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

Fainting and fatigue may signal onset of variant, experts say

LOS ANGELES — With monkeypox on the rise, Lady Kay decided to hold off on meeting clients in hotel rooms or private dungeons.

Omicron’s mutations impaired vaccine effectiveness, CDC says

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

Anti-lockdown advocates have been claiming online this week that Victoria's Chief Health Officer Brett Sutton admitted that vaccines never worked. But that's not what he said.

NEW YORK — Novak Djokovic’s refusal to get the COVID-19 vaccine has seemingly cost him another shot at a tournament.

From next week people in Ireland who are at high risk of getting monkeypox will be offered a dose.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help